Abacavir: A new nucleoside reverse transcriptase inhibitor

Journal of Gynecologic Surgery

Volumn 14, Issue 4, 1998, Pages 199-200

  Osborne, Newton G ^a  

^a HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; AMPRENAVIR; DIDANOSINE; INDINAVIR; NEVIRAPINE; RITONAVIR; SAQUINAVIR; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; CLINICAL TRIAL; DRUG HYPERSENSITIVITY; DRUG METABOLISM; DRUG POTENCY; ENZYME INHIBITION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; SHORT SURVEY; VIRUS INHIBITION;

EID: 0032416656     PISSN: 10424067     EISSN: None     Source Type: Journal    
DOI: 10.1089/gyn.1998.14.199     Document Type: Short Survey

References (7)

1. UNAIDS. Report on the global HIV/AIDS epidemic. Presented at the 12th World AIDS Conference, June 28-July 3, Geneva.
2. Centers for Disease Control and Prevention. Diagnosing and reporting HIV and AIDS in the states with integrated HIV and AIDS surveillance: United States, January 1994-June 1997. MMWR 1998;47:309.
3. Osborne NG. HIV exposure. J Gynecol Surg 1996;12:223.
4. Osborne NG. The fertile woman infected with HIV. J Gynecol Surg 1998;14:151.
5. Carpenter CCJ, Fischl MA, Hammer SM, et al. Antiretroviral therapy for HIV infection in 1998. JAMA 1998;280:78.
6. Foster RH, Faulds D. Abacavir. Drugs 1998;55:729.
7. James JS. 1592 (abacavir): Do not rechallenge after hypersensitivity treatment. AIDS Treat News 1997;1:5.